Cargando…

Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year

BACKGROUND AND OBJECTIVES: Some disease-modifying treatments impair response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in multiple sclerosis (MS), potentially increasing the risk of breakthrough infections. We aimed to investigate longitudinal SARS-CoV-2 antibody dynam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Disanto, Giulio, Galante, Alice, Cantu', Marco, Sacco, Rosaria, Mele, Federico, Eisler, Jennifer Jessica, Keller, Franco, Bernasconi, Enos, Sallusto, Federica, Zecca, Chiara, Gobbi, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747147/ https://www.ncbi.nlm.nih.gov/pubmed/36396447 http://dx.doi.org/10.1212/NXI.0000000000200043

Ejemplares similares

Influence of Disease Modifying Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Vaccination on Coronavirus Disease 2019 Risk and Outcome in Multiple Sclerosis and Neuromyelitis Optica
por: Eisler, Jennifer Jessica, et al.
Publicado: (2023)

Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
por: Scotti, Barbara, et al.
Publicado: (2018)

Use of glatiramer acetate between 2010–2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients
por: Zecca, Chiara, et al.
Publicado: (2019)

Increasing cancer risk over calendar year in people with multiple sclerosis: a case–control study
por: Zecca, Chiara, et al.
Publicado: (2020)

Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parameters
por: Riccitelli, Gianna C., et al.
Publicado: (2021)

Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple Sclerosis
por: Ostini, Camilla, et al.
Publicado: (2021)

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study
por: Zecca, Chiara, et al.
Publicado: (2017)

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment
por: Caporro, Matteo, et al.
Publicado: (2014)

Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping
por: Sparasci, Davide, et al.
Publicado: (2022)

Migraine in Multiple Sclerosis Patients Affects Functional Connectivity of the Brain Circuitry Involved in Pain Processing
por: Pravatà, Emanuele, et al.
Publicado: (2021)

Postvaccine Myocarditis: A Risk Worth the Reward?
por: Raman, Betty, et al.
Publicado: (2022)

Clinical Characteristics of COVID-19 Patients' Postvaccination
por: Zhang, Xiao-Bin, et al.
Publicado: (2022)

Postvaccination Acute Exacerbations of Idiopathic Pulmonary Fibrosis?
por: Huang, Jin-Xian, et al.
Publicado: (2022)

Postvaccine myocarditis and the use of antipyretics: Is there any relation?
por: Fatima, Maurish, et al.
Publicado: (2023)

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
por: Disanto, Giulio, et al.
Publicado: (2017)

Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis
por: Rogalewski, Andreas, et al.
Publicado: (2007)

Three Rotavirus Outbreaks in the Postvaccine Era — California, 2017
por: Burke, Rachel M., et al.
Publicado: (2018)

Postvaccination COVID-19 among Healthcare Workers, Israel
por: Amit, Sharon, et al.
Publicado: (2021)

Postvaccination COVID-19 among Healthcare Workers, Israel
por: Yousaf, Zohaib, et al.
Publicado: (2021)

Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
por: Oechtering, Johanna, et al.
Publicado: (2021)

Pathological studies on postvaccinal reactions of Rift Valley fever in goats
por: Kamal, Samia Ahmed
Publicado: (2009)

Glycomic Signatures on Serum IgGs for Prediction of Postvaccination Response
por: Wang, Jing-Rong, et al.
Publicado: (2015)

Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature
por: Liverani, Carlo A., et al.
Publicado: (2020)

COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance?
por: Samuel, Samson Mathews, et al.
Publicado: (2022)

COVID-19 Infection in Heart Transplants in Pre- and Postvaccination Periods
por: Donoso Trenado, Víctor, et al.
Publicado: (2022)

Intrathecal Administration of High-Titer Cytomegalovirus Immunoglobulin for Cytomegalovirus Meningitis
por: Fujiwara, Shin-ichiro, et al.
Publicado: (2014)

Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin
por: Abghari, Pamella F., et al.
Publicado: (2017)

Therapeutic Immunoglobulin Selected for High Antibody Titer to RSV also Contains High Antibody Titers to Other Respiratory Viruses
por: Orange, Jordan S., et al.
Publicado: (2015)

Vaccine-Associated Disease Enhancement (VADE): Considerations in Postvaccination COVID-19
por: Tunjungputri, Rahajeng N., et al.
Publicado: (2021)

Characteristics of Postvaccination Coronavirus Disease 2019 Hospitalizations Prior to Booster Vaccines
por: Moffa, Matthew A, et al.
Publicado: (2022)

Immune Repertoire of Sheep Blood B-Cells in the Postvaccination Immune Response
por: Ezdakova, I. Yu., et al.
Publicado: (2022)

Pollen Allergy Screening with Allergen-Specific and Total Immunoglobulin E Titers
por: Yokoi, Hidenori, et al.
Publicado: (2022)

Development, validation and clinical usefulness of a prognostic model for relapse in relapsing-remitting multiple sclerosis
por: Chalkou, Konstantina, et al.
Publicado: (2021)

Neurologic complications of acute hepatitis E virus infection
por: Ripellino, Paolo, et al.
Publicado: (2019)

Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras
por: Riddell, Michaela A, et al.
Publicado: (2005)

Adenovirus-associated Deaths in US Military during Postvaccination Period, 1999–2010
por: Potter, Robert N., et al.
Publicado: (2012)

Postvaccinal Encephalitis after ChAdOx1 nCov‐19
por: Zuhorn, Frédéric, et al.
Publicado: (2021)

Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response
por: Mahmoud, Sally A., et al.
Publicado: (2021)

Targeting SARS-CoV-2 papain-like protease in the postvaccine era
por: Ton, Anh-Tien, et al.
Publicado: (2022)

COVID-19 Severity in Kidney Transplant Recipients According to Their Postvaccination Serological Assessment
por: Masset, Christophe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qp4nevgqag6pqsdijep8gkue34